Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) closed the day trading at $0.57 down -4.10% from the previous closing price of $0.59. In other words, the price has decreased by -$4.10 from its previous closing price. On the day, 5.0 million shares were traded.
Ratios:
For a better understanding of IRWD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 0.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1.18. For the most recent quarter (mrq), Quick Ratio is recorded 3.34 and its Current Ratio is at 3.34.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 ’25 when MCCOURT Thomas A bought 14,661 shares for $0.59 per share.
Gaskins Tammi L bought 2,814 shares of IRWD for $1,660 on May 19 ’25. On Feb 10 ’25, another insider, MCCOURT Thomas A, who serves as the Chief Executive Officer of the company, sold 139,064 shares for $1.76 each. As a result, the insider received 244,753 and left with 1,160,634 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $7.11, while it has fallen to a 52-week low of $0.59. The 50-Day Moving Average of the stock is -48.05%, while the 200-Day Moving Average is calculated to be -82.10%.
Shares Statistics:
A total of 161.81M shares are outstanding, with a floating share count of 156.67M. Insiders hold about 3.18% of the company’s shares, while institutions hold 95.52% stake in the company.
